Risk factor analysis in myelodysplastic syndrome patients with del(20q): prognosis revisited
Open Access
- 30 November 2006
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 171 (1) , 9-16
- https://doi.org/10.1016/j.cancergencyto.2006.06.003
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Additional cytogenetic changes and previous genotoxic exposure predict unfavorable prognosis in myelodysplastic syndromes and acute myeloid leukemia with der(1;7)(q10;p10)Cancer Genetics and Cytogenetics, 2006
- Prognostic significance of del(20q) in patients with hematological malignanciesCancer Genetics and Cytogenetics, 2005
- The World Health Organization (WHO) classification of the myeloid neoplasmsBlood, 2002
- Myelodysplastic syndrome: review of the cytogenetic and molecular dataCritical Reviews in Oncology/Hematology, 2001
- Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genesOncogene, 2000
- Refinement of the Smallest Commonly Deleted Segment of Chromosome 20 in Malignant Myeloid Diseases and Development of a PAC-Based Physical and Transcription MapGenomics, 2000
- MyelodysplasiaNew England Journal of Medicine, 1999
- Cytogenetic analysis in the diagnosis of acute leukemiaCancer, 1992
- Chromosomal deletions in the myelodysplastic syndromeLeukemia Research, 1992
- A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical courseBlood, 1988